Legend Biotech Corp. (LEGN)
18.48
-1.32
(-6.67%)
USD |
NASDAQ |
Oct 16, 16:00
18.48
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Research and Development Expense (Annual) : 415.80M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 415.80M |
| December 31, 2024 | 413.75M |
| December 31, 2023 | 382.22M |
| December 31, 2022 | 335.65M |
| December 31, 2021 | 313.35M |
| Date | Value |
|---|---|
| December 31, 2020 | 232.56M |
| December 31, 2019 | 161.94M |
| December 31, 2018 | 60.64M |
| December 31, 2017 | 8.195M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| Ionis Pharmaceuticals, Inc. | 913.18M |
| Johnson & Johnson | 14.83B |
| Arbutus Biopharma Corp. | 25.24M |
| Capricor Therapeutics, Inc. | 83.50M |